Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Laser guided by High-Tech camera could zap skin cancer with less scarring

NCT ID NCT04744935

Disease control Sponsor: Christopher Zachary Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a laser, guided by a special camera (OCT), can effectively treat basal cell carcinoma, a common skin cancer. About 40 adults with confirmed BCC will receive the laser treatment. The goal is to see if the cancer is completely removed, potentially offering a less invasive option with better cosmetic results.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
1064 nm long-pulse Nd:YAG laser
What this could lead to
If successful, this could offer a precise, less invasive treatment for basal cell carcinoma with better cosmetic outcomes.
What could go wrong
This is a small, early-stage trial with only 40 participants. The laser may not clear all cancer cells, and long-term effectiveness is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2021

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability to understand and carry out subject instructions or be represented by a legally authorized guardian or representative * Ages 18 and older * Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy Exclusion Criteria: Any of the following will exclude participation in the study: * Inability to understand and/or carry out instructions * Patients with a BCC lesion that requires excision. This would include relatively large lesions (\>2.5 cm diameter), lesions that penetrate deep into the skin beyond the depth of the OCT image capture, high risk lesions as defined by the American Academy of Dermatology as recurrent and sclerosing subtype BCC, or metastases. * Patients with periocular BCCs which might expose the patient to risk of damage to eyes from the laser. * BCCs on legs due to their tendency towards poor wound healing. * Pregnancy * Patients unable to follow-up for the full 12 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Basal cell carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

basal cell carcinoma nodular basal cell carcinoma superficial multifocal basal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Basal cell carcinoma Nodular basal cell carcinoma Superficial basal cell carcinoma

Contacts and locations

Locations

  • UCI Health Dermatology Clinic

    Irvine, California, 92617, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.